On the road

Continuous manufacturing can go anywhere in the world by boat or helicopter, says Pfizer's expert

Pfizer hails portable manufacturing as latest in lean

By Fiona Barry

How can a pharma company invest in continuous manufacturing without bleeding money when it retreats from a local market? Pfizer’s answer is production pods it can roll out anywhere in the world via helicopter… and pack away again if a market turns.

University of Texas has spent seven years developing a nasal spray vaccine against Ebola

DISPATCHES FROM AAPS 2014

Ebola nasal vaccine under threat as funding runs dry

By Dan Stanton

Lack of funding is threatening development of a nasal spray vaccine shown to provide long-term protection for non-human primates against the Ebola virus, the lead researcher told this publication in an exclusive interview.

Protective equipment for health workers in Guinea. (Picture: EC/ECHO/Jean-Louis Mosser)

Dispatches from AAPS 2014

BARDA: Ebola is “a bioterrorism threat”

By Fiona Barry

BARDA, the US government’s Biomedical Advanced Research and Development Authority, has revealed it sees Ebola “as a bioterrorism threat.”